OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials
- First Posted Date
- 2005-10-17
- Last Posted Date
- 2014-12-19
- Target Recruit Count
- 119
- Registration Number
- NCT00239356
- Locations
- 🇬🇧
Local Institution, Antrim, United Kingdom
A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices
- Conditions
- Schizophrenia
- First Posted Date
- 2005-10-13
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 1200
- Registration Number
- NCT00237939
- Locations
- 🇪🇸
Local Institution, Sevilla, Spain
Schizophrenia Trial of Aripiprazole
- Conditions
- Schizophrenia
- Interventions
- First Posted Date
- 2005-10-13
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 700
- Registration Number
- NCT00237913
- Locations
- 🇬🇧
Local Institution, Birmingham, West Midlands, United Kingdom
A Switch Study of BMS-337039 in Schizophrenic Out-patients
- First Posted Date
- 2005-10-05
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 450
- Registration Number
- NCT00232687
- Locations
- 🇬🇧
Local Institution, Haywards Health, West Sussex, United Kingdom
"SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia
- Conditions
- HyponatremiaWater IntoxicationInappropriate ADH SyndromeWater-electrolyte Imbalance
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2012-05-03
- Target Recruit Count
- 243
- Registration Number
- NCT00201994
- Locations
- 🇩🇪
Universitatskilinikum Carl, Gustav Carus, Dresden, Germany
Study of Rebamipide Eye Drops to Treat Dry Eye
- Conditions
- Keratoconjunctivitis Sicca
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2006-11-02
- Target Recruit Count
- 740
- Registration Number
- NCT00201955
- Locations
- 🇺🇸
Vision Incorporated, Savannah, Georgia, United States
🇺🇸Philadelphia Eye Associates, Philadelphia, Pennsylvania, United States
🇺🇸Western Wake Eye Center, P.A., Cary, North Carolina, United States
Study of Rebamipide Eye Drops to Treat Dry Eye
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2008-01-07
- Target Recruit Count
- 740
- Registration Number
- NCT00201981
- Locations
- 🇺🇸
Montana Medical Research, LLC, Missoula, Montana, United States
🇺🇸Sall Eye Research Center, Artesia, California, United States
🇺🇸Western New York Eye Center, Orchard Park, New York, United States
Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure
- Conditions
- Heart Failure, Congestive
- First Posted Date
- 2005-08-22
- Last Posted Date
- 2012-05-03
- Target Recruit Count
- 140
- Registration Number
- NCT00132886
- Locations
- 🇺🇸
Robert Rush University Medical Center, Chicago, Illinois, United States
🇺🇸Loyola University of Chicago, Maywood, Illinois, United States
🇺🇸Cleveland VA Medical Center, Cleveland, Ohio, United States
Aripiprazole in Children and Adolescents With Bipolar I Disorder
- First Posted Date
- 2005-05-10
- Last Posted Date
- 2012-05-21
- Target Recruit Count
- 296
- Registration Number
- NCT00110461
- Locations
- 🇺🇸
Local Institution, Milwaukee, Wisconsin, United States
A Study of Aripiprazole in Patients With Major Depressive Disorder
- Conditions
- Major Depressive Disorder
- Interventions
- Drug: Aripiprazole+ ADTDrug: Placebo+ ADT
- First Posted Date
- 2005-03-10
- Last Posted Date
- 2013-12-02
- Target Recruit Count
- 349
- Registration Number
- NCT00105196
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
🇺🇸Clinical Research Institute, Witchita, Kansas, United States
🇺🇸Uptown Research Institute, Llc, Chicago, Illinois, United States